ArticleEuropean journal of cancer (Oxford, England : 1990)2021

NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.

Carl M Thielmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.